Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Pediatric blood disorders include a wide range of conditions that affect red blood cells, white blood cells, and platelets, as well as blood proteins related to bleeding and clotting disorders. Some of these conditions are inherited and passed down from parents who carry the abnormal (mutated) gene. Others are acquired.
The Blood Disorders Center provides comprehensive diagnostic, treatment, and preventive services for a wide range of non-malignant blood disorders. Your child will receive care from some of the world's most experienced hematologists with deep expertise in the conditions they treat. Our Center combines the resources and expertise of a world-class cancer center and a world-class pediatric hospital through the partnership between Dana-Farber Cancer Institute and Boston Children's Hospital.
See a list of the childhood blood disorders we treat.
Our multidisciplinary approach to care ensures personalized management plans that meet the medical, physical, emotional, and informational needs of each hematology patient and family. Our blood disorders team integrates expertise from:
See a complete list of our childhood blood disorders treatment team.
As a national leader in pediatric cancer and blood disorder clinical research and care, Dana-Farber/Boston Children's Cancer and Blood Disorders Center offers innovative treatment options and clinical trials. Our laboratory discoveries frequently lead to new clinical treatments that minimize the impact of these (often) lifelong conditions. Our physicians lead many National Institutes of Health-sponsored clinical trials and networks overseeing studies for thalassemia, transfusion medicine, hemostasis, sickle cell disease, and more.
Learn more about clinical trials for blood disorders offered through Dana-Farber/Boston Children's.
New Patient Appointments